Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol Kit
Product Images NDC 60505-4895

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol (NDC 60505-4895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister-plain-2.jpg (Blister Plain 2)

Blister-plain-2.jpg (Blister Plain 2)
This text seems to be a description of a medication package containing Desogestrel and Ethinyl Estradiol Tablets, USP as well as Ethinyl Estradiol Tablets USP in different dosage strengths. The medication is indicated for specific weeks of use, with different colored tablets provided for each week. The package should be stored at a controlled room temperature and out of reach of children. It is manufactured by Naari Pharma Private Limited in India for Apotex Corp.*
FDA Label Image

Blister-plain-final.jpg (Blister Plain Final)

Blister-plain-final.jpg (Blister Plain Final)
This is a medication package containing Desogestrel and Ethinyl Estradiol Tablets. The package includes white, yellow, and light green tablets to be taken over a 28-day period. The dosage of Ethinyl Estradiol in the tablets is 0.15 mg/0.02 mg and 0.01 mg, and they should be stored at 20° to 25°C (68° to 77°F). The package is manufactured by Naari Pharma Private Limited in India for Apotex Corp. It is important to keep these tablets out of reach of children.*
FDA Label Image

Blister-with Palm-2.jpg (Blister With Palm 2)

Blister-with Palm-2.jpg (Blister With Palm 2)
This is a prescription label for a medication called Desogestrel and Ethinyl Estradiol Tablets, USP containing Ethinyl Estradiol Tablets USP at different dosages. It provides instructions for use over the course of a four-week cycle and storage recommendations. The medication is manufactured by Apotex Corp. in Weston, Florida, USA, and is made in India by Naari Pharma Private Limited. It also includes a reminder to keep the medication out of reach of children.*
FDA Label Image

Blister-with Palm-final.jpg (Blister With Palm Final)

Blister-with Palm-final.jpg (Blister With Palm Final)
This is a prescription only medication called Desogestrel and Ethinyl Estradiol Tablets used for birth control. It contains 0.15 mg of Ethinyl Estradiol and 0.02 mg of Desogestrel. The medication should be stored at 20°C to 25°C. The manufacturer is Apotex Corp based in Weston, Florida, USA, while it is manufactured by Naari Pharma Private Limited in India. Be sure to keep the medication out of reach of children.*
FDA Label Image

Carton-apotex-final.jpg (Carton Apotex Final)

FDA Label Image

Description (Description)

FDA Label Image

Figure 1.jpg (Figure 1)

Figure 1.jpg (Figure 1)
This text provides information on mortality rates based on the number of deaths per 100,000 woman-years, with data shown for different age groups. The source of the data is adapted from P.M. Layde and V. Beral, reference number 12. Additionally, the text mentions "EVER-USERS" categorized by smoking status and controls for comparison.*
FDA Label Image

Figure 2.jpg (Figure 2)

FDA Label Image

Table 1.jpg (Table 1)

Table 1.jpg (Table 1)
This is a detailed pharmacokinetic profile of Etonogestrel and Desogestrel with Ethinyl Estradiol. It includes information on dose, peak concentration, time to peak concentration, half-life, area under the curve (AUC), and clearance. These data are vital for understanding the absorption, distribution, metabolism, and excretion of these hormones, which can help in optimizing dosing regimens and monitoring therapeutic levels.*
FDA Label Image

Table2-final.jpg (Table2 Final)

Table2-final.jpg (Table2 Final)
This text provides data on the annual number of birth-related or method-related deaths associated with fertility control methods per 100,000 non-sterile women, categorized by age groups. The text includes information on different methods of fertility control such as oral contraceptives, condoms, diaphragm/spermicide, and periodic abstinence, and presents statistics on deaths based on age ranges. The data distinguishes between deaths that are birth-related and those that are method-related.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.